Lawyers Comment On High Court's Pay-For-Delay Decision
The U.S. Supreme Court ruled Monday that brand-name drugmakers can be sued for paying generic-drug manufacturers to delay the release of low-cost versions of blockbuster medicines, overturning an Eleventh Circuit finding...To view the full article, register now.
Already a subscriber? Click here to view full article